I'm not surprised that they moved to subscription. But an annual $5000 buy in to give someone the opportunity to pay to use apps is ridiculous.
Unconfigured Ad
Collapse
X
-
To be fair, that $5k (if that is what the cost of the mid-tier subscription is) appears to include two additional features.Originally posted by thermophile View PostI'm not surprised that they moved to subscription. But an annual $5000 buy in to give someone the opportunity to pay to use apps is ridiculous.
Whether "Multi-user access" and 8hr of bioinformatics professional services support is worth $5K, is open to debate
If you don't have any local IT infrastructure then that may be your sole option.
Comment
-
-
Software release note for 2.18 has this listed as "known issue"Originally posted by kcchan View PostThat issue still hasn't been fixed as of the the most recent 2.18 update.
“N” is incorrectly allowed as an index sequence character in the sample sheet. When used, this will cause a mismatch for any sequence character other than “N”.
Comment
-
-
Does that apply to all apps or just the third party ones that we would normally be paying for? Right now, it looks like the usual basic analyses I'm used to running are still accessible from a basic account, but I think my account is still on a trial basis from the changeover.Originally posted by kcchan View PostI would imagine some of the third party developers aren't too happy either since their apps are now stuck behind a paywall.
Comment
-
-
Wait, so we can't even do FastQC with a free account? I was able to run it, but like I said yesterday, my account is still in trial mode. Are you just trying to use the Illumina/BaseSpace Labs 16s metagenomics app? I'm not hopeful for my Amplicon DS analyses, then....Originally posted by thermophile View PostI can select a sample, launch FastQC or 16S metagenomics, but then I don't have the start button
Comment
-
-
Jessica, I can't run any apps at all. My understanding is that every new account gets a 30day trial so I guess you could just make a new email and account every month to continue using the apps.Microbial ecologist, running a sequencing core. I have lots of strong opinions on how to survey communities, pretty sure some are even correct.
Comment
-
-
While that may work short term, it may land you on Illumina's blacklist (if they watch for what IP's the accounts are logging in from).Originally posted by thermophile View PostJessica, I can't run any apps at all. My understanding is that every new account gets a 30day trial so I guess you could just make a new email and account every month to continue using the apps.
Small cores may need to adjust their prices (and account for $5K subscription) if they find BaseSpace indispensable for daily business.
Comment
-
-
True. I'm likely going to go back to ignoring the basespace apps and use it just for fastq distribution which is still currently feasible for my miseq only core on a free account.Originally posted by GenoMax View PostWhile that may work short term, it may land you on Illumina's blacklist (if they watch for what IP's the accounts are logging in from).
Small cores may need to adjust their prices (and account for $5K subscription) if they find BaseSpace indispensable for daily business.Microbial ecologist, running a sequencing core. I have lots of strong opinions on how to survey communities, pretty sure some are even correct.
Comment
-
Latest Articles
Collapse
-
by SEQadmin2
Data variability is still an issue in sequencing technologies despite the advances in reproducibility and accuracy of these platforms. But the problem does not originate in the sequencing itself, but in the previous steps, before the sample reaches the sequencer.
The first step is collection, followed by preservation and sample preparation for analysis. Most scientists overlook those steps, but not being careful might just be skewing the experiment’s results.
...-
Channel: Articles
06-02-2026, 10:05 AM -
-
by SEQadmin2
With the launch of new single-cell sequencing platforms in 2026, the field stands at an exciting inflection point. This article surveys the most impactful advances in the field and discusses how they’re reshaping research in cancer, immunology, and beyond.
Introduction
Single-cell sequencing technologies have undergone remarkable advances over the past decade, transitioning from low-throughput experimental approaches to highly scalable platforms capable of...-
Channel: Articles
05-22-2026, 06:42 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Today, 10:09 AM
|
0 responses
9 views
0 reactions
|
Last Post
by SEQadmin2
Today, 10:09 AM
|
||
|
Started by SEQadmin2, Yesterday, 08:59 AM
|
0 responses
14 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 08:59 AM
|
||
|
Started by SEQadmin2, 06-02-2026, 12:03 PM
|
0 responses
24 views
0 reactions
|
Last Post
by SEQadmin2
06-02-2026, 12:03 PM
|
||
|
Started by SEQadmin2, 06-02-2026, 11:40 AM
|
0 responses
20 views
0 reactions
|
Last Post
by SEQadmin2
06-02-2026, 11:40 AM
|
Comment